EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors

EGFR806-specific CAR T-cell therapy - Cellevolve Bio, Seattle Children’s Therapeutics

http://clinicaltrials.gov/ct2/show/NCT03638167

Jan 20, 2023